Paul Roumeliotis
Overview
Explore the profile of Paul Roumeliotis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sihota A, Bonell C, Buffone B, Houle S, Kani M, Kim J, et al.
Can Pharm J (Ott)
. 2024 Sep;
157(5):209-217.
PMID: 39310803
No abstract available.
2.
Houle S, Johal A, Roumeliotis P, Roy B, Boivin W
Can Pharm J (Ott)
. 2024 May;
157(3):123-132.
PMID: 38737362
Background: In Canada, influenza vaccination rates are below recommended targets, with pharmacies the leading setting for vaccine administration. This work aimed to determine the Canadian public's current knowledge, attitudes and...
3.
Houle S, Johal A, Roumeliotis P, Roy B, Boivin W
Pharmacy (Basel)
. 2024 Apr;
12(2).
PMID: 38668096
Vaccination rates against both influenza and COVID-19 fall short of targets, especially among persons at risk of influenza complications. To gain insights into strategies to boost influenza vaccine coverage, we...
4.
Roumeliotis P, Houle S, Johal A, Roy B, Boivin W
Vaccines (Basel)
. 2023 Aug;
11(8).
PMID: 37631946
The Public Health Agency of Canada recommends that 80% of high-risk persons, including adults aged ≥65 years and 18-64 years with certain comorbidities, be vaccinated against influenza. During the 2022-2023...
5.
Fisher W, Gilca V, Murti M, Orth A, Garfield H, Roumeliotis P, et al.
Vaccines (Basel)
. 2023 Jan;
11(1).
PMID: 36679861
This study evaluated the impact of a continuing medical education (CME) program that emphasized actionable information, motivation to act, and skills to strengthen physician recommendations for seasonal influenza vaccination in...
6.
Fisher W, Gilca V, Murti M, Orth A, Garfield H, Roumeliotis P, et al.
Vaccines (Basel)
. 2022 Nov;
10(11).
PMID: 36423052
Adjuvanted trivalent influenza vaccine (aTIV) provides enhanced protection against seasonal influenza in children compared with nonadjuvanted trivalent influenza vaccine (TIV). This prospective cohort study assessed parental attitudes, beliefs, and intentions...
7.
Fisher W, Gilca V, Murti M, Orth A, Garfield H, Roumeliotis P, et al.
Vaccines (Basel)
. 2022 Nov;
10(11).
PMID: 36423050
This prospective cohort survey evaluated the concordance of clinicians’ perceptions of parental intentions and parents’ actual intentions to vaccinate their infants against influenza. During a routine healthy baby visit, clinicians...
8.
Fisher W, Gilca V, Murti M, Orth A, Garfield H, Roumeliotis P, et al.
Vaccines (Basel)
. 2022 Oct;
10(10).
PMID: 36298633
The adjuvanted trivalent influenza vaccine (aTIV) provides enhanced protection against influenza for infants but is not publicly funded (NPF). The objective of this prospective cohort study of parents with children...
9.
Dennis C, Marini F, Dick J, Atkinson S, Barrett J, Bell R, et al.
BMJ Open
. 2021 Feb;
11(2):e046311.
PMID: 33568380
Introduction: The 'Developmental Origins of Health and Disease' hypothesis suggests that a healthy trajectory of growth and development in pregnancy and early childhood is necessary for optimal health, development and...
10.
Sampasa-Kanyinga H, Roumeliotis P, Xu H
PLoS One
. 2014 Jul;
9(7):e102145.
PMID: 25076490
Purpose: The negative effects of peer aggression on mental health are key issues for public health. The purpose of this study was to examine the associations between cyberbullying and school...